Page last updated: 2024-08-18

cyclohexanol and Dysthymic Disorder

cyclohexanol has been researched along with Dysthymic Disorder in 19 studies

Research

Studies (19)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (26.32)	18.2507
2000's	13 (68.42)	29.6817
2010's	1 (5.26)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bombardier, CH; Brooks, L; Fann, JR; Heinemann, AW; McCullumsmith, CB; Richards, JS; Tate, DG; Temkin, NR; Warms, C; Warren, AM; Wilson, CS	1
Cunha, FT; Ladeira, RB; Nicolato, R; Salgado, JV; Teixeira, AL	1
Frare, F; Perugi, G; Ruffolo, G; Toni, C; Torti, C	1
Alamo, C; López-Muñoz, F; Rubio, G; San, L	1
Devanand, DP; Fitzsimons, L; Juszczak, N; Nobler, MS; Roose, SP; Sackeim, HA; Turret, N	1
Berger, M; Feige, B; Nissen, C; Nofzinger, E; Riemann, D; Voderholzer, U	1
Bastiaens, L	1
Ashton, AK; Longdon, MC	1
Black, JL; McAlpine, DE; Mrazek, DA; O'Kane, DJ	1
Benazzi, F	1
Bea, C; Budech, CB; Dunner, DL; Hendrickson, HE	1
Joffe, RT; Lee, DK; Marshall, AM	1
al-Zaid, K; Anisman, H; Charbonneau, Y; Ravindran, AV; Wiens, A; Zaharia, MD	1
Batchelder, ST; Fedak, MJ; Hellerstein, DJ; Kreditor, D; Little, SA; Rosenthal, J	1
Anisman, H; Griffiths, J; Merali, Z; Ravindran, AV; Zaharia, MD	1
Ballús, C; Casais, L; De Flores, T; de la Torre, J; Gutiérrez, M; Palao, D; Quiros, G; Riesgo, Y; Rojo, L	1
Golden, RN; Nicholas, L	1
Nayudu, S; Scheftner, WA; Shulman, RB	1
Devarajan, S; Dursun, SM; Haddad, PM	1

Reviews

1 review(s) available for cyclohexanol and Dysthymic Disorder

Article	Year
Antidepressant efficacy of venlafaxine. Depression and anxiety, 2000, Volume: 12 Suppl 1 Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Humans; Treatment Outcome; Venlafaxine Hydrochloride	2000

Trials

10 trial(s) available for cyclohexanol and Dysthymic Disorder

Article	Year
Venlafaxine extended-release for depression following spinal cord injury: a randomized clinical trial. JAMA psychiatry, 2015, Volume: 72, Issue:3 Topics: Adolescent; Adult; Chronic Disease; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Spinal Cord Injuries; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2015
Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response. Neuropsychobiology, 2002, Volume: 46, Issue:3 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Outpatients; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride	2002
Reboxetine adjunct for partial or nonresponders to antidepressant treatment. Journal of affective disorders, 2004, Volume: 81, Issue:1 Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Dysthymic Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Personality Inventory; Prospective Studies; Reboxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2004
An open treatment trial of venlafaxine for elderly patients with dysthymic disorder. Journal of geriatric psychiatry and neurology, 2004, Volume: 17, Issue:4 Topics: Aged; Cyclohexanols; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2004
Venlafaxine in dysthymic disorder. The Journal of clinical psychiatry, 1997, Volume: 58, Issue:12 Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysthymic Disorder; Female; Humans; Male; Personality Inventory; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride	1997
A large open-label study of venlafaxine in depressed outpatients by community-based physicians. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:10 Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Community Medicine; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Dysthymic Disorder; Family Practice; Female; Humans; Male; Middle Aged; Nausea; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia	1998
Efficacy and tolerability of venlafaxine in the treatment of primary dysthymia. Journal of psychiatry & neuroscience : JPN, 1998, Volume: 23, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Dysthymic Disorder; Female; Humans; Male; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1998
Venlafaxine in the treatment of dysthymia: an open-label study. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:12 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Administration Schedule; Dysthymic Disorder; Fatigue; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Patient Dropouts; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia	1999
Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features. Journal of affective disorders, 2000, Volume: 58, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Female; Fluoxetine; Humans; Immune Tolerance; Lymphocyte Activation; Male; Middle Aged; Paroxetine; Personality Inventory; Sertraline; Venlafaxine Hydrochloride	2000
The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia. International clinical psychopharmacology, 2000, Volume: 15, Issue:1 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	2000

Other Studies

8 other study(ies) available for cyclohexanol and Dysthymic Disorder

Article	Year
[Combining venlafaxine and mirtazapine for the treatment of major depression with dysthymia--"double depression"]. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2008, Volume: 30, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Dysthymic Disorder; Female; Humans; Mianserin; Mirtazapine; Venlafaxine Hydrochloride	2008
Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine. Journal of sleep research, 2005, Volume: 14, Issue:2 Topics: Adult; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Narcolepsy; Polysomnography; Substance Withdrawal Syndrome; Treatment Failure; Venlafaxine Hydrochloride	2005
Adolescents' response to antidepressant treatment in a community mental health center. Community mental health journal, 2005, Volume: 41, Issue:1 Topics: Adolescent; Adolescent Psychiatry; Algorithms; Antidepressive Agents; Child; Child Psychiatry; Citalopram; Community Mental Health Centers; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2005
Hyperprolactinemia and galactorrhea induced by serotonin and norepinephrine reuptake inhibiting antidepressants. The American journal of psychiatry, 2007, Volume: 164, Issue:7 Topics: Adrenergic Uptake Inhibitors; Adult; Cyclohexanols; Duloxetine Hydrochloride; Dysthymic Disorder; Female; Galactorrhea; Humans; Hyperprolactinemia; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride	2007
Cytochrome P450 2D6 genotype variation and venlafaxine dosage. Mayo Clinic proceedings, 2007, Volume: 82, Issue:9 Topics: Adolescent; Adult; Alleles; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Cytochrome P-450 CYP2D6; Delayed-Action Preparations; Depressive Disorder, Major; Dysthymic Disorder; Female; Genotype; Humans; Male; Middle Aged; Retrospective Studies; Treatment Failure; Venlafaxine Hydrochloride	2007
Venlafaxine withdrawal symptoms. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1996, Volume: 41, Issue:7 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Administration Schedule; Dysthymic Disorder; Humans; Male; Phobic Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	1996
Venlafaxine-associated mania. Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:2 Topics: Adult; Bipolar Disorder; Cyclohexanols; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2001
Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'. Journal of psychopharmacology (Oxford, England), 2001, Volume: 15, Issue:2 Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Diagnosis, Differential; Dysthymic Disorder; Female; Humans; Paroxetine; Stroke; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2001